AbCellera Biologics Inc.
$6,325,000.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2022-2023
- Agreement period
- November 1, 2022 – March 31, 2024
- Reference
- nrc-cnrc:172-2022-2023-Q4-1002444
Published purpose
Identify and develop antibody therapeutics for response and preparedness against COVID-19, and expand capacity for rapid development and delivery of antibody therapeutics.
In plain English AI-generated
Funding to AbCellera Biologics Inc. to identify and develop antibody therapeutics for COVID-19 response and preparedness, and to expand capacity for rapid antibody development and delivery.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.